Comparative effectiveness of tocilizumab versus TNF inhibitors as monotherapy or in combination with conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis after the use of at least one biologic disease-modifying antirheumatic drug: Analyses from the pan-European TOCERRA register collaboration
Lauper K et al. Ann Rheum Dis 2018; Advance online publication. doi: 10.1136/annrheumdis-2017-212845
Please follow the link below to view this article in full on a third-party website. Note that a subscription or payment may be required.